Yasutomo Fujii
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Comparison of the effects of peficitinib and tofacitinib in the adjuvant-induced arthritis rat model.
Journal: European journal of pharmacology
Published: September 23, 2022
Peficitinib inhibits fibroblast-like synoviocyte activation and angiogenic vascular endothelial tube formation via inhibitory effects on PDGF and VEGF signaling in addition to JAK.
Journal: Journal of pharmacological sciences
Published: March 14, 2022
Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test.
Journal: Scientific reports
Published: December 20, 2021
Correction to: Inhibitory effects of ultrasound irradiation on Staphylococcus epidermidis biofilm.
Journal: Journal of medical ultrasonics (2001)
Published: October 16, 2021
Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice.
Journal: Journal of pharmacological sciences
Published: July 12, 2021
Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates.
Journal: Journal of medical ultrasonics (2001)
Published: February 03, 2021
Inhibitory effects of ultrasound irradiation on Staphylococcus epidermidis biofilm.
Journal: Journal of medical ultrasonics (2001)
Published: November 23, 2020
Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
Journal: Modern rheumatology
Published: April 04, 2020
In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors.
Journal: Rheumatology (Oxford, England)
Published: July 08, 2019
Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Journal: European journal of pharmacology
Published: June 21, 2019
Last Updated: 09/26/2026